Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao; José Luis Górriz Teruel; Luis D¿Marco; Enrique Garrigós; Gema Fernández-Fresnedo; Eugenia Espinel Garuz; Secundino Cigarrán Guldris; Jesús Arteaga Coloma; Nicolas Roberto Robles Pérez-Monteoliva; José Rafael Esteban de la Rosa; Luis Javier Nieto Iglesias; Alberto Ortiz Arduán; Juan Francisco Navarro-González;

Social determinants of health influencing the choice of dialysis modality in advanced chronic kidney disease: Need of an interdisciplinary approach María Dolores Arenas; Marisol Fernández-Chamarro; Guillermo Pedreira-Robles; Silvia Collado; Julia Farrera; Isabel Galceran; Francesc Barbosa; Higini Cao; Alicia Moreno; Laura Morro; Jose Luis Fernández-Martin; Marta Crespo; Julio Pascual;

Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio Anna Vidal-Alabró; Helena Colom; Pere Fontova; Gema Cerezo; Edoardo Melilli; Nuria Montero; Ana Coloma; Anna Manonelles; Alex Favà; Josep M. Cruzado; Joan Torras; Josep M. Grinyó; Nuria Lloberas;